| 08:30-08:40 |
Optimization of chitosan/hyaluronic acid-based hybrid patchs for anti-adhesive and prevention of anastomosis leakage |
°¼öÁø |
°æºÏ´ëÇб³º´¿ø |
|
| 08:40-08:50 |
Anticancer effect of PLK1 degrading PROTAC in colorectal cancer |
°µ¿Çö |
¼øÃµÇâ´ëÇб³ õ¾Èº´¿ø |
|
| 08:50-09:00 |
Rearrangement of actomyosin cytoskeleton modulated with 3D-spheroids via RhoA/ROCK in internal anal sphincter-targeting model; preliminary results |
¼ÕÀÏÅÂ |
ÇѸ²´ëÇб³ ¼º½Éº´¿ø |
|
| 09:00-09:10 |
Impact of contrast phases on area and radiodensity measurements of skeletal muscle and adipose tissue |
°Á¤Çö |
¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø |
|
| 09:10-09:20 |
Appendicitis-targeted generative enhanced image synthesis and three-dimensional deep learning-based diagnosis in non-contrast CT |
±è¹Î¼º |
ÇѸ²´ëÇб³ ¼º½Éº´¿ø |
|
| 09:20-09:30 |
Metagenomic profiling of the gut microbiome for predicting complete response to total neoadjuvant treatment in rectal cancer |
ÇãÁö¿ø |
Ãæ³²´ëÇб³ »ý¸íÁ¤º¸À¶ÇÕÇаú |
|
| 08:30-08:40 |
Spatial transcriptomic analysis for genetic profiling of colitis-associated colorectal cancer in ulcerative colitis |
¹ÚÀºÁ¤ |
¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼¿ï¾Æ»êº´¿ø |
|
| 08:40-08:50 |
Comparing surgical outcomes between Crohn’s disease and Gastrointestinal Behcet’s disease: a single-center retrospective cohort study |
½Åµ¿Çö |
¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø |
|
| 08:50-09:00 |
Impact of aged care facility residence on 30-day mortality after emergency abdominal surgery for acute abdomen in the elderly |
±èÁÖ¿¬ |
±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø |
|
| 09:00-09:10 |
Analysis of extraintestinal manifestations in Korean patients with inflammatory bowel disease; A nationwide population-based study |
¹Ú¼º½Ç |
ÇѾç´ëÇб³º´¿ø |
|
| 09:10-09:20 |
¿°Áõ¼º ÀåÁúȯÀÇ Ä¡·á °æÇâ º¯È: ´ÜÀϱâ°ü ÈÄÇâÀû ºÐ¼® |
¹è¿¹ÁØ |
°í·ÁÀÇ´ë |
|
| 09:20-09:30 |
Comparison of hernia surgery outcomes in patients with and without prior prostatetectomy or cystectomy: A propensity score-matched analysis |
À¯È¿¼± |
°í·Á´ëÇб³ ¾È¾Ïº´¿ø |
|
| 08:30-08:40 |
Long-term outcomes according to the management of responsive lateral nodes after CCRT followed by rectal cancer surgery (RESPONDER): A multicenter retrospective cohort study using IPTW |
¿ÀÈï±Ç |
ºÐ´ç¼¿ï´ëÇб³º´¿ø |
|
| 08:40-08:50 |
Albumin-myosteatosis gauge, a novel predictor of postoperative complication in colorectal cancer surgery with nomogram |
Á¶ÇýÁ¤ |
¿¬¼¼´ëÇб³ Àǰú´ëÇÐ °³²¼¼ºê¶õ½ºº´¿ø |
|
| 08:50-09:00 |
Serial ctDNA analysis in stage IV colorectal cancer |
¹®Áö¿¬ |
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø |
|
| 09:00-09:10 |
Size matters: Establishing a cut-off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines |
±è¼¼Á¤ |
¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ |
|
| 09:10-09:20 |
Comparative analysis of clinical characteristics between recurrence and non-recurrence patients after 5 years in colorectal cancer |
¹ÚÁ¦¼º |
¼¿ï´ëÇб³º´¿ø |
|
| 09:20-09:30 |
Neoadjuvant chemotherapy with four cycles of FOLFOX for locally advanced colon cancer: A multicenter prospective randomized controlled trial |
¹Ú¼ö¿¬ |
°æºÏ´ëÇб³ Àǰú´ëÇÐ |
|
| 17:00-17:10 |
Optimal indocyanine green dosage for repetitive angiography for laparoscopic colorectal surgery |
¼Õ°æ¸ð |
¾ç»êºÎ»ê´ëÇб³º´¿ø |
|
| 17:10-17:20 |
Role of tumor microenvironment in the development of cancer cachexia |
±èÈ£½Â |
ÀÌÈÀÇ´ë |
|
| 17:20-17:30 |
Biomarkers for predicting therapeutic response to preoperative chemoradiotherapy in rectal cancer |
ÀÌÃæ¿± |
¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼¿ï¾Æ»êº´¿ø |
|
| 17:30-17:40 |
Mechanistic insights into radiation resistance in colorectal cancer: Gene exploration study |
À̼öÇö |
¼øÃµÇâÀÇ´ë õ¾Èº´¿ø |
|
| 17:40-17:50 |
Identification of arginine (di)methylated human leukocyte antigen class I peptides in colon cancer tissues from patients |
ÀÓ¿ëö |
¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ |
|
| 17:50-18:00 |
Early postoperative fever - when is it a reason to delay discharge after colorectal cancer surgery? |
¹ÚÀçÇö |
¼¿ï´ëÇб³º´¿ø |
|
| 17:00-17:10 |
Two-week course versus conventionally fractionated preoperative chemoradiotherapy in locally advanced rectal cancer (TwoArc trial): A phase III multicenter randomized clinical trial |
°èºÀÇö |
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø |
|
| 17:10-17:20 |
Implications of CME as a predictive factor for peritoneal recurrence of cT3-4 right-sided colon cancer: A multicenter retrospective study |
¼Û½ÂÈ£ |
Ä¥°î°æºÏ´ëº´¿ø |
|
| 17:20-17:30 |
The clinical utility of blood-based multi-locus circulating tumor DNA methylation assay for colorectal cancer diagnosis: Prospective case-control study, interim results |
ÀÌÇÏ¿µ |
°µ¿°æÈñ´ëº´¿ø |
|
| 17:30-17:40 |
Pilot study of implementing prehabilitation program to rectal cancer patients undergoing preoperative concurrent chemoradiation therapy |
À¯´Ï³ª |
°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø |
|
| 17:40-17:50 |
Nomogram for prediction of lymph node metastasis after neoadjuvant chemoradiotherapy in ypT0-2 rectal cancer |
¹ÚÇü¹Î |
ȼøÀü³²´ëÇб³º´¿ø |
|
| 17:50-18:00 |
Endoscopic treatment for rectal neuroendocrine tumors: Comparison among EMR, EMR-P, and ESD |
ÀÌÀºÁ¤ |
À寰À§Æ°º´¿ø |
|
| 17:00-17:10 |
Impact of inferior mesenteric artery ligation level on anastomotic leakage in low anterior resection: A multicenter RCT |
±èâÇö |
Àü³²´ëÇб³ Àǰú´ëÇÐ |
|
| 17:10-17:20 |
Prognostic factors and oncologic benefits of adjuvant chemotherapy in pT3N0 rectal cancer after upfront surgery |
°°æ¹Î |
ºÐ´ç¼¿ï´ëÇб³º´¿ø |
|
| 17:20-17:30 |
Watch-and-wait policy to defer defunctioning stoma after low anterior resection: Preliminary results from the safe anastomosis project |
±èÇýÁø |
°æºÏ´ëÇб³ Àǰú´ëÇÐ |
|
| 17:30-17:40 |
Comparison of long-term oncological outcomes between robotic and laparoscopic total mesorectal excision for rectal cancer: A propensity score matching analysis |
¹è¼º¿í |
°è¸íÀǴ뵿»êÀÇ·á¿ø |
|
| 17:40-17:50 |
Optimal age cut-off for oxaliplatin-based versus non-oxaliplatin adjuvant chemotherapy in stage II/III colorectal cancer: A Korean population-based study |
ºÀÁØ¿ì |
°í·Á´ëÇб³ ±¸·Îº´¿ø |
|
| 17:50-18:00 |
Risk factors for LN metastasis in T1 colorectal cancer : A retrospective, single-center, comparative study |
¹ÚÁøÇü |
°¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø |
|